Organized by Institute of Clinical Medicine at the University of Oslo. Program: 14:30 Introduction Guttorm Haraldsen, Department of Pathology and K.G. Jebsen Inflammation Research Centre, University of Oslo (UiO) and OUH. 14:40 Natural killer T-cell activation – inhibition by self lipids. Espen Melum, Norwegian PSC Research Center, OUH. 15:00 Gene discoveries in multiple sclerosis: Novel […]

Norsk Biotekforum og  Smerud Medical Research International AS  inviterer til møte i møteserien om klinisk utprøvning.  Registration Program: Kliniske studier innenfor cancer immunterapi  – Introduksjon  v/Knut T. Smerud, Smerud Medical Research International AS Faglig bakgrunn for immunoterapi og oversikt generelt om temaet – Professor Gustav Gaudernack, Oslo Universitetssykehus Bedriftspresentasjoner: o   Ultimovacs AS v/Øyvind Arnesen, CEO […]

R&D Christmas Network: “New insights in immuno-oncology” This meeting is kindly sponsored by the Radium Hospital Foundation (Radiumhospitalets legater). Download program   Moderator: Gunnar Kvalheim, Head of the Department of Cellular Therapy, OUS PROGRAM 14:00–14:15 Registration and coffee 14:15 – 14:20: Funding opportunities -Ole Johan Borge, Innovation Norway 14:20–14:40 Welcome and Update – short introduction […]

Hva er immunonkologi og hvorfor er det et medisinsk gjennombrudd? Hva betyr dette for klinisk praksis, pasientene og samfunnet? I flere tiår har forskere og leger opparbeidet seg kliniske erfaringer på hvordan man kan påvirke immunforsvaret hos kreftpasienter til å eliminere sykdommen. Dette fagfeltet kalles immunonkologi. Behandlingen baserer seg på å påvirke pasientens eget immunforsvar […]

This is the first seminar in our educational series on cancer immunotherapies featuring: Novel treatment strategies and their clinical implementation in melanoma and beyond. Download PROGRAM here If you for some reason may not attend, please let us know 24 hours prior to the event. You may watch the live streaming of this event following this […]

2015 Annual Meeting of the Association for Cancer Immunotherapy May 11-13 Conference registration is open Take advantage of early-registration fees for CIMT 2015. After March 27, 2015, a 10% surcharge will apply http://www.meeting.cimt.eu/register CIMT 2015 abstract submission ongoing through February 27 Present your research at CIMT 2015 by submitting your abstract today. All accepted abstracts […]

Oslo Cancer Cluster will be presenting at this 3rd CIMT Endeavour Workshop on Translating cancer science into products and companies. The Endevaour workshop is a part of the annual CIMT Meeting, which is Europe’s largest immuno-oncology meeting. The concept of CIMT Endeavour is to organize and build-up a unique and focused education and networking platform […]

Kreftforeningen og Oslo Cancer Cluster inviterer til frokostmøte om bruk av immunterapi som kreftbehandling.  Vi ønsker med dette å gi journalister, fagfolk og politikere en kort introduksjon til et spennende område innen moderne kreftbehandling, både fra forsknings- og utviklingssiden: «Immunterapi som kreftbehandling – et paradigmeskrifte?» Møt de ledende forskerne og ressurspersoner innen fagfeltet – få […]

Tuesday, October 6, 2015 // 2:00-3:15pm EDT // 11:00am-12:15pm PDT US Join a live web panel, hosted by ShareVault, Defined Health, Pullan Consulting and the Biotechnology Industry Organization (BIO), discussing what’s exciting and not so exciting in immuno-oncology drug development, and why. Register here For the live event, biotech licensing and pharmaceutical business development consultant Linda Pullan will […]

We welcome all clinicians and academics in the field to this second meeting in our Immuno-oncology Educational Series of 2015. This meeting is mainly for clinicians and academics, but we open up for 1 participant per company. Oslo Cancer Cluster’s members BMS and MSD kindly support this Educational Series and BTO is our local partner.  […]

 Find link to previous webinar on this topic here. Dear Sir or Madam, Join us for the continuation of the discussion from October 6’s live web panel. Hosted by LES, ShareVault, Defined Health, Pullan Consulting, The Trout Goup and the Biotechnology Industry Organization (BIO), this sequel will continue to discuss what’s exciting and not so exciting […]

Oslo Cancer Cluster, Bristol-Myers Squibb and Janssen is pleased to welcome you to the annual Cancer Crosslinks conference, for the first time in the new Oslo Cancer Cluster Innovation Park. We are proud to feature a really strong program with great international key-notes.   Please register below. Registration for lunch and networking evening are binding. […]

PCI Biotech invites to a presentation of the company’s fourth quarter and preliminary full year 2015 report on Tuesday 9 February 2016 at Oslo Cancer Cluster Innovation Park. Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park If you wish to participate at the presentation, please confirm with an e-mail to […]

Nordic Nanovector and the Department of Radiation Biology at the Institute of Cancer Research invite all interested parties to a lecture on *Pretargeted radioimmunotherapy of multiple myeloma and malignant lymphoma* by Dr. Damian J. Green. Dr. Green is assistant professor at the University of Washington School of Medicine and has a lab at Fred Hutchinson […]

Discover the power and application of the worlds most advanced mouse models developed specifically to answer the challenges faced by researchers in Oncology, Immuno-Oncology and Infectious Disease. Attend an event in this European Symposia series at a location closest to you and empower your research with the latest scientific insight from industry leading scientists from […]

BIO-Europe Spring® 2016 — 10th International Partnering Conference – Where the global biotech industry comes to partner Stockholm, Sweden Program:  http://www.ebdgroup.com/bes/program/index.php Registration:  http://www.ebdgroup.com/bes/registration/index.php Discount: Oslo Cancer Cluster´s members receive a 200EUR discount. The discount code is “Oslo Cancer Cluster BES16 discount”. “The discount code needs to be noted in the comment field. The discount cannot be applied if […]

Oslo Cancer Cluster, Bristol-Meyers Squibb and MSD continues to deliver the much appreciated immuno-oncology educational series in 2016. The first meeting in Oslo features international key note Professor Petri Bono from Helsinki University Hospital. As this is an educational seminar for clinicians we to limit the number of company representative to one per company. We will […]

The Norwegian Society for Immunology is hosting their annual conference on the Day of Immunology on April 29. The theme for 2016 is Immunotherapy for Cancer and the event is open for any one interested in the theme. Please see program below or download program here and register at the bottom of this page.   Questions […]

Kl 1000 – Velkommen ved Silke Appel, leder Norsk Selskap for Immunologi, Bergen branch Kl 1005 – Moderne kreftbehandling – immunterapi ved Olav Dahl, professor, Klinisk institutt 2, UiB, og overlege kreftavdelingen, Haukeland universitetssykehus Kl 1015 – Hva er checkpoint inhibitorer? ved Eirik Bratland, forsker, Klinisk institutt 2, UiB Kl 1045 – Checkpoint inhibitorer i behandling av melanoma ,ved […]

CIMT Annual Meeting – May 10-12, 2016 “Mechanisms of Efficacy” The 14th Annual Meeting of the Association for Cancer Immunotherapy connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2016 is expected to bring together 1,000 international participants for […]

Oslo Cancer Cluster is co-hosting the 4th CIMT Endeavour Workshop on Translating cancer science into products and companies. The Endevaour workshop is a part of the annual CIMT Meeting, which is Europe’s largest immuno-oncology meeting. The concept of CIMT Endeavour is to organize and build-up a unique and focused education and networking platform that addresses […]

The focus of the symposium will be on Immuno-Oncology with the following international speakers. Inger Andersson, Chairman of IVA’s Biotechnology – Introduction Professor Kjell Strandberg, former DG MPA – What is immune oncology? Magnus Jäderberg, CMO Targovax, London – The new cancer drugs in a clinical perspective Professor Peter Nygren, Department of Oncology, University Hospital, Uppsala – Faster approvals […]

Welcome to the fourth Cancer Crosslink Sweden October 19, 2016, at Medicon Village, Lund Mission By bringing together researchers from healthcare providers, academia, and industry with representatives from regulatory units in a one-day meeting, we want to start an interdisciplinary discussion that could lead to new partnerships to develop the area of Personalized Medicine and […]

Ny terapi i kreft gjør at vi nå kan vente oss banebrytende gjennombrudd. Tekna har i samarbeid med Oslo Cancer Cluster og Kreftforeningen utviklet en konferanse som samler trådene fra de nye trendene innen kreftterapi og gir et innblikk i fremtidens krefttilbud. Nye kliniske studier innen ulike teknologi- og behandlingsmetoder Hvordan blir fremtidens kreftpakker med en […]

Seminar of the KG Jebsen Center for Cancer Immunotherapy, co-hosted by Oslo Cancer Cluster   Speaker: Bob Valamehr, Vice President, Cancer Immunotherapy at Fate Therapeutics Inc Moderator: Kalle Malmberg, KG Jebsen Center for Cancer Immunotherapy   Program will be available soon. Here is the invitation: KG Jebsen Seminar_FEb 17th  

War on Cancer Nordics 2017 in Oslo will gather leaders in oncology from the Nordic region and beyond, to discuss the region’s primary challenges in cancer care and control. The event will bring together policy makers, NGOs, academia, research and health care professionals, patient groups and cancer control institutes with private sector business leaders. Register […]

The Norwegian Society for Immunology (NSI) invites you to the Day of Immunology. Please sign up here before April 12th Please download program here Free entrance. Everybody is welcome! But note that there is a limited number of seats Morning session (populærvitenskapelige foredrag på norsk) 10.00: Velkomstkaffe 10.30: Velkommen Elisabeth Authen Sethre, Kreftforeningen 10.45: Hvordan fungerer immunsystemet egentlig? […]

The Norwegian Inflammation Network (NORIN) in partnership with Oslo Cancer Cluster welcomes you to: “Unintended consequences: autoimmunity as an adverse effect of modern immunotherapy in cancer”. Register here Download program This meeting is sponsored by Abbvie, Janssen and Takeda. Program 15:00 Welcome 15:10-15:50 Asim Amin, Levine Cancer Institute, Carolinas Medical Center “Immunotherapy for Cancer: A double-edged […]

RADIUM er en podkast som tar for seg kreft, kreftforskning og følger med på selskapene Radiumhospitalets forskningsstiftelse (RADFORSK) har investert i. Sjekk podkasten her. Nå for første gang med live innspilling! Temaet denne fredagen er investeringer i selskaper som utvikler kreftbehandling, men diskusjonene vil også ta for seg hele helseindustrien. Kreftforeningens generalsekretær Anne Lise Ryel […]

PLEASE NOTE:  Online registration is closed.  To join, please register on-site.   You are cordially invited to an informal networking reception.  Attendees can use this opportunity to connect to a group of Nordic Immuno-Oncology companies, learn more about their technologies, preclinical and clinical assets, and discuss scientific and other collaboration opportunities. The companies participating in this […]

PLEASE NOTE:  Online registration is closed.  To join, please register on-site. You are invited to learn more about clinical strategies in Immuno-Oncology (I-O) and meet 12 Nordic Companies advancing a broad range of technologies, preclinical and clinical stage I-O assets.  This event presents a special opportunity to meet, and discuss scientific and other collaboration opportunities in […]

Live podkast fra Radiumhospitalets forskningsstiftelse (RADFORSK). Temaet vil være «Persontilpasset kreftmedisin – en nær framtid takket være norsk forskning?» Moderator: Jónas Einarsson og Elisabeth Kirkeng Andersen Norsk forskning og teknologi kan i nær framtid bidra til at kreftpasienter får rett behandling til rett tid, tilpasset den kreftformen akkurat de har. Professor Erik Fosse og professor […]

AXL inhibition as a novel treatment of aggressive disease Short presentations will be given by our investigators and AXL KOLs in a relaxed atmosphere. Presentations will be made available in the investors section following the event. For further details and to receive an invitation please contact: priya.nanduri@bergenbio.com ASCO Personal Invitation

Er du investor eller gründerspire? Vi trenger deg! Norge har en sterk tradisjon innen kreftforskning i verdensklasse. Basert på denne fremragende forskningen har selskaper som Algeta, Nordic Nanovector, Ultimovacs og Zelluna Immunotherapy blitt spunnet ut. Og det kommer mer. Inven2 inviterer investorer, gründerspirer og andre interesserte til en presentasjon av de mest lovende nye prosjektene […]

Ved hjelp av genanalyse fant norske forskere medisin som virket på pasienter med kreft i siste stadie. Arrangører: Bioteknologirådet, Kreftforeningen, OCC Oslo Cancer Cluster Norske forskere har nylig klart å analysere genene i kreftcellene til 26 kreftpasienter med spredning hvor det ikke fantes behandling. Flere av pasientene fikk en medisin som virket. Dette gjennombruddet gir […]

From diagnosis to immunotherapy – why is precision medicine so difficult? The NTNU and HUNT research center welcomes oncologists, basic scientists, researchers and others with interest in the cancer biomarker field to join this second International Cancer Biomarker Symposium in Trondheim. This year a full day´s program will focus on all aspects of clinical immunotherapy, […]

One and a half year it has been since Jonas Einarsson, CEO at RADFORSK and Elisabeth Kirkeng Andersen, Communication Specialist at RADFORSK, started podcasting on cancer research, innovation and treatment from their investment portfolio. They have now reached the milestone of 50 episodes of their podcast, a pod that is followed on a weekly basis […]

Oslo Cancer Cluster, Kreftforeningen og Oslo Kommune ønsker velkommen til politikse møte om “Den digitale kreftpasient og pakkeforløp hjem”. Hvem bestemmer, hvem betaler og hvem driver utviklingen? Hva er mulig, hvem tar ansvar, hvilken grad er det distributivt? Foreløpig program: Del 1: Lansering av Tim film – Anne Lise og Robert Steen Del 2: Ansvar […]

18TH International Conference  On Progress In Vaccination Against Cancer. PIVAC-18 is a highly focused meeting devoted entirely to the development and use of immunotherapies against cancer, in particular cancer vaccines. It reflects the commitment to bring together leading international experts and hosts dedicated to the progress of cancer vaccination, the impact the tumour microenvironment and […]